Beta Bionics, Inc. (BBNX)

Beta Bionics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	17.48	26.57	27.68
Short-Term Investments	43.42	70.18	-
Cash & Short-Term Investments	60.9	96.75	27.68
Cash Growth	-	249.58%	-
Receivables	7.46	4.45	-
Inventory	11.29	1.25	-
Prepaid Expenses	2.6	0.91	0.54
Other Current Assets	0.31	0.28	0.25
Total Current Assets	82.56	103.62	28.47
Property, Plant & Equipment	11.04	6.2	6.87
Other Long-Term Assets	0.25	0.22	0.19
Total Assets	96.94	110.04	35.53
Accounts Payable	2.85	1.17	0.43
Accrued Expenses	11.46	7.07	6.14
Current Portion of Leases	1.45	1.22	0.98
Current Unearned Revenue	0.55	0.09	-
Other Current Liabilities	1.57	1.05	1.32
Total Current Liabilities	17.88	10.61	8.87
Long-Term Leases	5.85	3	3.16
Long-Term Unearned Revenue	1.47	0.26	-
Other Long-Term Liabilities	38.88	37.57	10.5
Total Liabilities	64.07	51.43	22.53
Common Stock	0	0	0
Additional Paid-In Capital	49.72	26.42	15.53
Retained Earnings	-278.63	-229.66	-185.57
Comprehensive Income & Other	0.06	0.14	-
Total Common Equity	-228.85	-203.11	-170.03
Shareholders' Equity	32.87	58.61	13
Total Liabilities & Equity	96.94	110.04	35.53
Total Debt	7.3	4.22	4.13
Net Cash (Debt)	53.6	92.52	23.54
Net Cash Growth	-	293.01%	-
Net Cash Per Share	4.72	8.85	2.39
Filing Date Shares Outstanding	42.86	9.91	9.85
Total Common Shares Outstanding	6.66	9.91	9.85
Working Capital	64.68	93.02	19.59
Book Value Per Share	-34.35	-20.50	-17.27
Tangible Book Value	-228.85	-203.11	-170.03
Tangible Book Value Per Share	-34.35	-20.50	-17.27
Machinery	7.52	5.78	5.56
Construction In Progress	1.01	0.17	0.18
Leasehold Improvements	0.81	0.95	0.95

Source: S&P Capital IQ. Standard template. Financial Sources.